Back to Search
Start Over
Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
- Source :
-
Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2016 Nov; Vol. 36 (4), pp. 705-717. Date of Electronic Publication: 2016 Sep 13. - Publication Year :
- 2016
-
Abstract
- The clinical efficacy of aspirin treatment after desensitization in patients with respiratory disease exacerbated by nonsteroidal anti-inflammatory drugs has been documented in observational studies and in double-blind placebo-controlled trials. There is no general agreement with regard to the optimal maintenance dose or duration of treatment with acetylsalicylic acid after desensitization, thus further studies are necessary to offer clear guidelines to clinicians. This article summarizes data from noncontrolled, active-control, and placebo-controlled trials assessing clinical effectiveness and reporting on safety of treatment with acetylsalicylic acid in desensitized patients with respiratory disease exacerbated by nonsteroidal anti-inflammatory drugs.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Subjects :
- Anti-Inflammatory Agents, Non-Steroidal adverse effects
Aspirin adverse effects
Desensitization, Immunologic
Drug Hypersensitivity etiology
Drug Hypersensitivity therapy
Humans
Randomized Controlled Trials as Topic
Respiratory Tract Diseases etiology
Respiratory Tract Diseases therapy
Treatment Outcome
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Aspirin therapeutic use
Clinical Trials as Topic
Subjects
Details
- Language :
- English
- ISSN :
- 1557-8607
- Volume :
- 36
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Immunology and allergy clinics of North America
- Publication Type :
- Academic Journal
- Accession number :
- 27712765
- Full Text :
- https://doi.org/10.1016/j.iac.2016.06.007